KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$119.0 million.

  • Amgen's Change in Inventory rose 6315.79% to -$119.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$886.0 million, marking a year-over-year increase of 6500.79%. This contributed to the annual value of -$886.0 million for FY2025, which is 6500.79% up from last year.
  • As of Q4 2025, Amgen's Change in Inventory stood at -$119.0 million, which was up 6315.79% from -$240.0 million recorded in Q3 2025.
  • Amgen's Change in Inventory's 5-year high stood at $241.0 million during Q3 2022, with a 5-year trough of -$806.0 million in Q1 2024.
  • Moreover, its 5-year median value for Change in Inventory was -$40.0 million (2021), whereas its average is -$150.1 million.
  • Per our database at Business Quant, Amgen's Change in Inventory soared by 40208.33% in 2022 and then plummeted by 230666.67% in 2024.
  • Quarter analysis of 5 years shows Amgen's Change in Inventory stood at -$50.0 million in 2021, then soared by 282.0% to $91.0 million in 2022, then tumbled by 729.67% to -$573.0 million in 2023, then soared by 43.63% to -$323.0 million in 2024, then skyrocketed by 63.16% to -$119.0 million in 2025.
  • Its Change in Inventory was -$119.0 million in Q4 2025, compared to -$240.0 million in Q3 2025 and -$239.0 million in Q2 2025.